Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)
Clinical trial NCT04845620 · COMPLETED
Trial details
- NCT number
- NCT04845620
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-07
- Primary completion
- 2023-06-01
- Enrollment
- 652
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.